Privia Health Earnings Call Highlights Growth And Cash

Privia Health Group, Inc. ((PRVA)) has held its Q4 earnings call. Read on for the main highlights of the call.

Privia Health Group’s latest earnings call struck a confident tone, with management emphasizing strong growth across providers, value-based lives, and profitability. Executives acknowledged some emerging headwinds around taxes, payer dynamics, and integration risk, but stressed that high cash generation, expanding margins, and a debt‑free balance sheet position the company well for 2026.

Provider Base Expands at Double-Digit Pace

Privia ended 2025 with 5,380 implemented providers, up 12.3% year over year and 130 higher than in Q3, underscoring sustained demand for its platform. For 2026, the company forecasts implemented providers will rise another 10.6% at the midpoint, signaling continued network scale and underpinning future revenue and earnings growth.

Value-Based Attributed Lives Surge Across Segments

Value-based attributed lives reached about 1.54 million at year-end 2025, a 22.7% jump driven by broad-based gains in commercial, Medicare, Medicare Advantage, and Medicaid membership. Management expects lives to edge up to roughly 1.58 million in 2026, maintaining growth while navigating regulatory and payer changes in government and commercial programs.

Practice Collections Deliver Solid Double-Digit Growth

Full-year practice collections climbed to $3.47 billion in 2025, up 16.9% from the prior year, while Q4 collections grew 9.6% versus the same quarter in 2024. Looking ahead, the company guides to more moderate 6.6% growth in 2026 at the midpoint as the base gets larger, but still sees healthy topline expansion supporting its value-based care strategy.

Adjusted EBITDA Jumps with Margin Expansion

Adjusted EBITDA rose 38.8% in 2025 to $125.5 million, with Q4 up 26.4% year over year to $31.5 million, reflecting strong operating execution. EBITDA margin as a share of care margin expanded by roughly 480 basis points to about 27.2% for the year, and near 27% in Q4, highlighting substantial efficiency gains as the model scales.

Free Cash Flow Outsized in 2025, Cash Pile Swells

The company converted an exceptional 130% of adjusted EBITDA to free cash flow in 2025, helped by favorable collections timing and working capital. Despite spending $180 million on transactions, Privia ended the year with roughly $480 million in cash and no debt, and projects cash to climb further in 2026 even with lower conversion rates.

Strategic M&A Extends National Footprint

Privia closed the acquisition of Evolent Health’s ACO business in December, adding over 120,000 attributed lives and deepening its presence in value-based care. The deal, plus entry into Arizona through anchor partner IMS, extends the company’s reach to 24 states and Washington, D.C., and management reports strong sales momentum in the new market.

Provider Retention and Patient Loyalty Remain Strong

Gross provider retention stayed extremely high at 98% in 2025, reinforcing the appeal of Privia’s model to physicians and care teams. Patient satisfaction also looked robust, with a Net Promoter Score of 87 across the footprint, suggesting strong engagement and a solid foundation for long-term value-based performance.

Operating Leverage and Cost Control Support Margins

Management highlighted operating leverage as costs for the platform and G&A fell as a percentage of revenue, helping practice collections and platform contribution land near the high end of guidance. The company sees further G&A leverage in 2026 and believes technology and AI investments can unlock additional productivity and margin improvement over time.

Tax Shift to Temper EBITDA-to-FCF Conversion

While cash generation remains healthy, Privia expects EBITDA-to-free-cash-flow conversion to normalize to about 80% in 2026 as it becomes a full cash taxpayer and runs through prior NOLs. This shift represents a headwind versus 2025’s 130% conversion, but reflects the company’s higher profitability and still leaves room for significant cash build.

Short-Term Variability in Practice Collections

Practice collections slipped modestly by about 40 basis points from Q3 to Q4 2025, and care center counts showed a slight rounding decline over the same period. Management attributed the softness mainly to prior-period true-ups and timing issues, flagging that quarter-to-quarter collections can be lumpy even as the full-year trend remains strong.

Payer and Program Changes Create Execution Risk

Executives pointed to ongoing uncertainty around Medicare Advantage, payer contracting, and evolving CMS models as potential headwinds for some patient cohorts. Shifts from older programs to new structures and pressure on payer economics could affect shared savings and contract terms, requiring careful negotiation and diversification to preserve margins.

Integration Challenges for the Evolent ACO Acquisition

The recently acquired Evolent ACO providers have not yet migrated to Privia’s technology and operating platform, delaying full synergy realization. Management acknowledged that implementing the Privia playbook and lifting savings rates to internal benchmarks will take time, representing an execution and timing risk before the asset reaches targeted profitability.

Uneven Market Profitability and Portfolio Pruning

Performance varies by geography, with some newer or smaller markets still generating negative EBITDA while mature markets post strong results. The company has shown willingness to exit underperforming areas, as seen with Delaware, and intends to selectively invest or prune to optimize returns and focus resources where economics are most attractive.

Regulatory and Enrollment Churn in ACA and Medicaid

Management highlighted potential volatility in ACA and Medicaid populations due to enrollment shifts and payer responses, which could influence utilization and payer mix. While they expect some churn in these books of business, the diversified nature of Privia’s model across payers and products is seen as a partial buffer against localized shocks.

Guidance Signals Continued Growth and Cash Strength

For 2026, Privia guides to approximately 10.6% provider growth, attributed lives of about 1.58 million, and practice collections up 6.6% at the midpoint. Care margin is projected to rise around 13%, adjusted EBITDA to roughly $150 million with about 80% converting to free cash flow, and cash balances to reach about $600 million with no debt by year end, assuming no further business development.

Privia’s earnings call painted a picture of a fast-growing, cash-rich platform steadily expanding its provider and patient base while widening margins. Investors will watch how the company manages tax headwinds, payer negotiations, and integration work, but the combination of strong fundamentals, high retention, and disciplined capital deployment keeps the long-term growth story intact.